Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,564 | 113,941 | 93,542 | 124,287 | 152,357 |
| Marketable Securities | 504,867 | 542,834 | 616,813 | 657,036 | 687,252 |
| Other current assets | 3,744 | 7,577 | 7,352 | 10,533 | 6,795 |
| TOTAL | $624,014 | $680,392 | $739,659 | $809,204 | $865,129 |
| Non-Current Assets | |||||
| PPE Net | 2,359 | 3,461 | 5,148 | 5,911 | 7,210 |
| Intangibles | 0 | 0 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 43,627 | 44,988 | 52,255 | 53,881 | 55,476 |
| TOTAL | $45,986 | $48,449 | $59,703 | $62,092 | $64,986 |
| Total Assets | $670,000 | $728,841 | $799,362 | $871,296 | $930,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,752 | 5,176 | 8,450 | 14,097 | 6,867 |
| Accrued Expenses | 25,132 | 23,215 | 20,990 | 21,236 | 33,216 |
| Other current liabilities | 1,078 | 609 | 1,682 | 1,990 | 1,356 |
| TOTAL | $32,605 | $32,525 | $37,052 | $50,729 | $46,968 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 7,679 | N/A |
| Other Non-Current Liabilities | 29,686 | 30,658 | 41,229 | 42,775 | 44,286 |
| TOTAL | $29,686 | $30,658 | $41,229 | $42,775 | $44,286 |
| Total Liabilities | $62,291 | $63,183 | $78,281 | $93,504 | $91,254 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 173,322 | 172,411 | 171,445 | 169,522 | 167,383 |
| Common Shares | 168 | 168 | 168 | 168 | 167 |
| Retained earnings | -1,959,879 | -1,885,730 | -1,815,355 | -1,738,290 | -1,662,286 |
| Other shareholders' equity | 493 | -163 | 38 | -991 | 2,509 |
| TOTAL | $607,709 | $665,658 | $721,081 | $777,792 | $838,861 |
| Total Liabilities And Equity | $670,000 | $728,841 | $799,362 | $871,296 | $930,115 |